Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Merck
Colorcon
Harvard Business School
AstraZeneca
Moodys
McKesson

Last Updated: December 9, 2019

DrugPatentWatch Database Preview

HYDROCHLOROTHIAZIDE; PROPRANOLOL HYDROCHLORIDE - Generic Drug Details

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What are the generic drug sources for hydrochlorothiazide; propranolol hydrochloride and what is the scope of patent protection?

Hydrochlorothiazide; propranolol hydrochloride is the generic ingredient in seven branded drugs marketed by Wyeth Ayerst, Wyeth Pharms Inc, Duramed Pharms Barr, Actavis Elizabeth, Ani Pharms Inc, Ivax Sub Teva Pharms, Mylan, Warner Chilcott, Watson Labs, and Yaopharma Co Ltd, and is included in twenty-one NDAs. Additional information is available in the individual branded drug profile pages.

There are thirty-two drug master file entries for hydrochlorothiazide; propranolol hydrochloride. One supplier is listed for this compound.

Recent Clinical Trials for HYDROCHLOROTHIAZIDE; PROPRANOLOL HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
VA Office of Research and DevelopmentN/A

See all HYDROCHLOROTHIAZIDE; PROPRANOLOL HYDROCHLORIDE clinical trials

Recent Litigation for HYDROCHLOROTHIAZIDE; PROPRANOLOL HYDROCHLORIDE

Identify potential future generic entrants

District Court Litigation
Case NameDate
Salix Pharmaceuticals, Inc. v. Teva Pharmaceuticals USA, Inc.2017-03-27
Wyeth v. Biovail Corporation2008-06-26
Plaintiff(s) v. Defendant(s)2008-01-31

See all HYDROCHLOROTHIAZIDE; PROPRANOLOL HYDROCHLORIDE litigation

Pharmacology for HYDROCHLOROTHIAZIDE; PROPRANOLOL HYDROCHLORIDE

US Patents and Regulatory Information for HYDROCHLOROTHIAZIDE; PROPRANOLOL HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Elizabeth PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; propranolol hydrochloride TABLET;ORAL 070851-001 May 15, 1986 DISCN No No   Start Trial   Start Trial   Start Trial
Ani Pharms Inc PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; propranolol hydrochloride TABLET;ORAL 070704-001 Oct 1, 1986 DISCN No No   Start Trial   Start Trial   Start Trial
Watson Labs PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; propranolol hydrochloride TABLET;ORAL 071498-001 Dec 18, 1991 DISCN No No   Start Trial   Start Trial   Start Trial
Duramed Pharms Barr PROPRANOLOL HYDROCHLORIDE & HYDROCHLOROTHIAZIDE hydrochlorothiazide; propranolol hydrochloride TABLET;ORAL 071126-001 Mar 2, 1987 DISCN No No   Start Trial   Start Trial   Start Trial
Wyeth Ayerst INDERIDE LA 160/50 hydrochlorothiazide; propranolol hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 019059-003 Jul 3, 1985 DISCN No No   Start Trial   Start Trial   Start Trial
Wyeth Pharms Inc INDERIDE-40/25 hydrochlorothiazide; propranolol hydrochloride TABLET;ORAL 018031-001 Approved Prior to Jan 1, 1982 DISCN Yes No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for HYDROCHLOROTHIAZIDE; PROPRANOLOL HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Wyeth Ayerst INDERIDE LA 120/50 hydrochlorothiazide; propranolol hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 019059-002 Jul 3, 1985   Start Trial   Start Trial
Wyeth Ayerst INDERIDE LA 80/50 hydrochlorothiazide; propranolol hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 019059-001 Jul 3, 1985   Start Trial   Start Trial
Wyeth Ayerst INDERIDE LA 160/50 hydrochlorothiazide; propranolol hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 019059-003 Jul 3, 1985   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Mallinckrodt
Moodys
Baxter
Colorcon
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.